HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.

Abstract
Pseudomonas aeruginosa is one of the most frequently isolated microorganisms in bacterial corneal ulcers in Japan and other countries. We evaluated a topical application of 0.3% ofloxacin (OFLX) for Pseudomonas corneal ulcer in rabbits and compared it to the clinical effects of OFLX in topical and oral applications. All corneas in the control groups of both experiments showed total leukoma with a score of 4 on the seventh day. On the other hand, in the preventive experiment, all the scores in the OFLX-treated group were 0, and those in the therapeutic experiment were smaller than those of both the control and oral groups. The results indicate that topical OFLX is effective on Pseudomonas corneal ulcer in rabbits.
AuthorsS Shiao, Y Isobe, H Hatano, S Ohno
JournalOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) Vol. 209 Issue 3 Pg. 155-9 ( 1995) ISSN: 0030-3755 [Print] Switzerland
PMID7630623 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Ophthalmic Solutions
  • Ofloxacin
Topics
  • Administration, Oral
  • Administration, Topical
  • Animals
  • Cornea (drug effects, microbiology, pathology)
  • Corneal Ulcer (drug therapy, microbiology, prevention & control)
  • Eye Infections, Bacterial (drug therapy, prevention & control)
  • Female
  • Ofloxacin (administration & dosage)
  • Ophthalmic Solutions
  • Pseudomonas Infections (drug therapy, prevention & control)
  • Pseudomonas aeruginosa (drug effects)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: